Ocular Delivery (Focus Group - OcD)

(425) Biocompatibility assessment of Dexamethasone-Loaded Hydrogel ocular Implants

(426) Developing ciprofloxacin-loaded HEMA contact lenses for sustained release.

(427) Apatinib-loaded polymeric micelles for ophthalmic delivery to the posterior segment

(428) Fenofibrate Eyedrop: A Novel Therapeutic Approach for Mustard Gas-Induced Corneal Injuries

(429) Development of PEG and VE containing block copolymer to form nanomicelles for ocular drug delivery

(430) Inspection of Ocular Drug Delivery Implants

(431) Cationic mucoadhesive Posaconazole NioTherms:A potential approach for management of Fungal Keratitis

(432) Mucoadhesive micelle for anterior segment ocular drug delivery

(433) DECON- a novel platform for Sustained Ocular Delivery of Corticosteroids

(434) Mucoadhesive Polymer-Drug Conjugate and Nanoparticle for Anterior Ophthalmic Drug Delivery

(435) Development of a Polymeric Nanofiber Device for the Prevention of Post-Surgical Secondary Cataracts

(436) Muco-penetrating nanoparticles to sustain drug release for ophthalmic drug delivery

(437) CBD Niosomes as an Innovative Strategy for the Treatment of Retinal Degenerative Diseases

(438) Autologous Serum ocular inserts for treatment of Dry Eye Disease

(439) Loteprednol etabonate-loaded nanoemulsion: anti-inflammatory effect

(440) A dissolvable gel-based in vitro dissolution method for in situ-forming implants

(441) Development of an in situ gelling ocular vehicle: A design of experiments (DOE) approach

(442) In vitro enzymatic degradation of PLGA microparticles

(443) Flavonoid loaded solid lipid nanoparticles in Pluronic gel for combating dry eye disease

(444) Synchronized Codelivery of Dexamethasone and Propranolol for the treatment of Macular Degeneration